ALKEM — Alkem Laboratories Balance Sheet
0.000.00%
- IN₹579.59bn
- IN₹552.08bn
- IN₹129.65bn
- 90
- 18
- 23
- 38
Annual balance sheet for Alkem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17,537 | 13,130 | 11,432 | 42,697 | 45,808 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 23,630 | 25,612 | 28,653 | 30,641 | 24,753 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 69,288 | 84,354 | 87,297 | 104,116 | 109,458 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 27,064 | 27,659 | 25,135 | 25,570 | 28,627 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 115,193 | 140,692 | 137,566 | 155,749 | 176,911 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 36,041 | 48,053 | 37,072 | 39,946 | 39,650 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 41,425 | 54,313 | 47,113 | 52,628 | 57,062 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 73,767 | 86,379 | 90,453 | 103,121 | 119,849 |
Total Liabilities & Shareholders' Equity | 115,193 | 140,692 | 137,566 | 155,749 | 176,911 |
Total Common Shares Outstanding |